Form 4: Phathom Pharmaceuticals CFO Molly Henderson Reports Stock Sale to Cover Tax Obligations

Molly Henderson, CFO and CBO of Phathom Pharmaceuticals, sold 3,435 shares of common stock on April 8, 2024, to cover tax withholding obligations related to the settlement of restricted stock units.

Summary

• On April 8, 2024, Molly Henderson, the CFO and CBO of Phathom Pharmaceuticals, sold 3,435 shares of the company's common stock.
• The sale was executed at a price of $11.1 per share.
• The transaction was conducted to satisfy tax withholding obligations arising from the settlement of restricted stock units.
• Following the transaction, Henderson directly owns 95,263 shares of Phathom Pharmaceuticals.
• Henderson also indirectly owns 1,911.27 shares through a 401(k) plan.

Sentiment

Score: 5

Explanation: This is a neutral event. The sale is related to tax obligations and doesn't necessarily reflect a change in the executive's confidence in the company.

Industry Context

Form 4 filings are a routine part of insider trading regulations, providing transparency into the transactions of company executives and directors. This filing indicates that the CFO sold shares to cover tax obligations, which is a common practice.

Stakeholder Impact

• The sale of shares by a company executive could be perceived negatively by some shareholders, although in this case it is for tax purposes.
• The impact is likely to be minimal as the number of shares sold is relatively small compared to the total outstanding shares.

Key Dates